TY  - GEN
AU  - Cohen,Jeffrey A
AU  - Khatri,Bhupendra
AU  - Barkhof,Frederik
AU  - Comi,Giancarlo
AU  - Hartung,Hans-Peter
AU  - Montalban,Xavier
AU  - Pelletier,Jean
AU  - Stites,Tracy
AU  - Ritter,Shannon
AU  - von Rosenstiel,Philipp
AU  - Tomic,Davorka
AU  - Kappos,Ludwig
TI  - Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study
SN  - 1468-330X
PY  - 2016///0829
KW  - Adult
KW  - Disability Evaluation
KW  - Double-Blind Method
KW  - Female
KW  - Fingolimod Hydrochloride
KW  - therapeutic use
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Interferon beta-1a
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Neuroimaging
KW  - Recurrence
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/jnnp-2015-310597
ER  -